Publications by authors named "Nigel P Murray"

Claim this Profile
M
Minimal Residual Disease in Breast Cancer: Tumour Microenvironment Interactions, Detection Methods and Therapeutic Approaches.
Nigel P Murray, Socrates Aedo

Int J Mol Sci· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravascular Lymphoma Presenting as Multiple Endocrine Failure, Transforming Into the Hemophagocytic Variant, and Relapsing as a Thrombotic Microangiopathy.
Nigel P Murray, Cinthia Escobar, Enrique Ramos, Claudia Perez, Dan Hartman

Case Rep Hematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomodulation and Immunotherapy for Patients with Prostate Cancer: An Up-to-Date Review.
Nigel P Murray

Biomedicines· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing a Burning Face: Clinical Manifestations and Therapeutic Approaches for Neurogenic Rosacea.
Gabriel Aedo, Marco Chahuán, Elsa Gatica, Isabel Herrera, Luis Felipe Parada, Nigel P Murray

Int J Mol Sci· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers of minimal residual disease and treatment.
Nigel P Murray

Adv Clin Chem· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Possible Role of Matrix Metalloprotienase-2 in the Relapse in Patients with Stage II Colon Cancer Treated by Curative Surgery.
Nigel P Murray, Ricardo Villalon, Socrates Aedo, Dan Hartmann, Maria P Rodriguez

Asian Pac J Cancer Prev· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The CAPRA-S Score and Immune Dysfunction as a Guide to Outcome in Men Treated with Prostatectomy Radical as Mono-Therapy for Prostate Cancer.
Nigel P Murray, Socrates Aedo, Cynthia Fuentealba, Eduardo Reyes, Aníbal Salazar

Arch Esp Urol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increasing Immune Dysfunction is Associated with Increasing Matrix-Metalloproteinase-2 Expression and Predicts Biochemical Failure in Men with Bone Marrow Micro-Metastasis Positive Localized Prostate Cancer.
Nigel P Murray, Socrates Aedo, Cynthia Fuentealba, Eduardo Reyes, Anibal Salazar

Asian Pac J Cancer Prev· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement in the Neutrophil-Lymphocyte Ratio after Combined Fluorouracil, Leucovorina and Oxaliplatino based (FOLFOX) Chemotherapy for Stage III Colon Cancer is Associated with Improved Minimal Residual Disease and Outcome.
Nigel P Murray, Ricardo Villalon, Dan Hartmann, Patricia Maria Rodriguez, Socrates Aedo

Asian Pac J Cancer Prev· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atypical presentation of COVID-19: Chronic bilateral testicular pain with lower extremity peripheral polyneuropathy, case report.
Aníbal Salazar, Agustín Gonzalez, Nigel P Murray, Carlos Castro

Urol Case Rep· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement in immune dysfunction after FOLFOX chemotherapy for Stage III colon cancer is associated with improved minimal residual disease prognostic subtype and outcome.
Nigel P Murray, Ricardo Villalon, Dan Hartmann, Maria Patricia Rodriguez, Socrates Aedo

Colorectal Dis· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transient acquired factor XII deficiency associated with moderately severe Covid-19 pneumonia.
Nigel P Murray, Eghon Guzman, Monica Del Prado

Hematol Transfus Cell Ther· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Dysfunction as Measured by the Systemic Immune-Inflammation Index is Associated with the Sub-Type of Minimal Residual Disease and Outcome in Stage II Colon Cancer Treated with Surgery alone.
Nigel P Murray, Ricardo Villalon, Shenda Orrego, Eghon Guzman

Asian Pac J Cancer Prev· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[CAPRA score vs minimal residual disease as predictors of biochemical recurrence after radical prostatectomy.].
Nigel P Murray, Cinthia Fuentealba, Eduardo Reyes, Anibal Salazar, Eghon Guzman

Arch Esp Urol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune dysfunction, minimal residual disease and patient outcome in nonmetastatic cancer: could modulation of immune function improve outcome?
Nigel P Murray

Future Oncol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal infarction associated with asymptomatic Covid-19 infection.
Nigel P Murray, Cynthia Fuentealba, Eduardo Reyes, Anibal Salazar

Hematol Transfus Cell Ther· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association of the neutrophil-lymphocyte ratio with the presence of minimal residual disease and outcome in patients with Stage II colon cancer treated with surgery alone.
Nigel P Murray, Ricardo Villalon, Shenda Orrego, Eghon Guzman

Colorectal Dis· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of mild congenital deficiency of Factor XI with a Factor XI inhibitor in pregnancy: A clinical case.
Nigel P Murray, Javier Ilabaca, Eghon Guzman, Shenda Orrega

Hematol Transfus Cell Ther· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subtypes of minimal residual disease and outcome for stage II colon cancer treated by surgery alone.
Nigel P Murray, Socrates Aedo, Ricardo Villalon, Vidal Albarran, Shenda Orrego

Ecancermedicalscience· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Epstein criteria predict for organ-confined prostate cancer but not for minimal residual disease and outcome after radical prostatectomy.
Nigel P Murray, Cynthia Fuentealba, Eduardo Reyes, Anibal Salazar, Eghon Guzman

Turk J Urol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The CAPRA-S score versus subtypes of minimal residual disease to predict biochemical failure after radical prostatectomy.
Nigel P Murray, Socrates Aedo, Cynthia Fuentealba, Eduardo Reyes, Anibal Salazar

Ecancermedicalscience· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The expression of matrix-metalloproteinase-2 in bone marrow micro-metastasis is associated with the presence of circulating prostate cells and a worse prognosis in men treated with radical prostatectomy for prostate cancer.
Nigel P Murray, Eduardo Reyes, Anibal Salazar, Marco Antonio Lopez, Shenda Orrego

Turk J Urol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The CAPRA score versus sub-types of minimal residual disease to predict biochemical failure after external beam radiotherapy.
Nigel P Murray, Socrates Aedo, Cynthia Fuentealba, Eduardo Reyes, Anibal Salazar

Ecancermedicalscience· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pregnancy in a 31-year-old woman with chronic lymphocytic leukemia: a case report and review of the literature.
Nigel P Murray, Shenda Orrego, Marco Antonio Lopez, Simona Minzer

Hematol Transfus Cell Ther· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platelet-to-lymphocyte ratio and systemic immune-inflammation index versus circulating prostate cells to predict significant prostate cancer at first biopsy.
Nigel P Murray, Cynthia Fuentealba, Aníbal Salazar, Eduardo Reyes

Turk J Urol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis